Trial intelligence / Profile preview

Vaginal Misoprostol Before Elective Cesarean Section

NCT03239327Unknown

Sponsor
Assiut University
Start
Jun 2016
Primary completion
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of misoprostol in neonatal respiratory distress syndrome (NRDS) (2 arms), sponsored by Assiut University. Primary endpoint: Rate of Neonatal Intensive Care Unit admission for neonatal respiratory distress at 24 hours. Status: unknown.

02

Drugs

misoprostol
03

Conditions

neonatal respiratory distress syndrome (NRDS)

Beyond the preview

Go deeper on NCT03239327.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03239327.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call